Immunovant 2024 J.P. Morgan Healthcare Conference Presentation

Immunovant presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024, showcasing its pipeline of targeted therapies for autoimmune diseases. The presentation discusses the development of batoclimab and IMVT-1402, highlighting their potential as first-in-class or best-in-class candidates across multiple autoimmune indications.